Diffuse Type Carcinoma
1 clinical trials · Condition
◉ Watch Diffuse Type Carcinoma
| Record | Firm | Date |
|---|---|---|
| Neo-Sequence 2：NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGC (NCT06371586) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-03-01 |
Track Diffuse Type Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.